Location

We are actively engaged in a search for the best site for the museum. Site selection will depend upon strong community, government, and philanthropic support.

Mace L. Rothenberg, MD is a medical oncologist with more than 30 years of experience spanning government, academia, and industry. Dr. Rothenberg served as Chief Medical Officer of Pfizer from 2019 to 2021 during which time the company initiated, completed, and obtained emergency use authorization for its COVID-19 vaccine. Prior to that role, Mace led Clinical Development for Oncology at Pfizer from 2008 to 2018. Over that 10 year period, his organization developed and obtained regulatory approval for 11 new cancer medicines. Dr. Rothenberg began his career as special assistant to the director of the Division of Cancer Treatment at the National Cancer Institute, then moved to the University of Texas Health Science Center at San Antonio, and then to Vanderbilt where he became professor of medicine and Ingram Professsor of Cancer Research at the Vanderbilt-Ingram Cancer Center. Dr. Rothenberg is a Fellow of the American College of Physicians and the American Society of Clinical Oncology. Dr. Rothenberg received his BA magna cum laude from the University of Pennsylvania, his MD from the New York University School of Medicine, his post-graduate training in Internal Medicine at Vanderbilt, and his
medical oncology training at the National Cancer Institute.